Ovarian and Cervical Cancer Screening: What Every Woman Should Know

Screening plays an essential role in detecting certain cancers early, especially those affecting the female reproductive system. While cervical cancer has well-established screening tools that have significantly reduced mortality rates, ovarian cancer remains more challenging to detect in its early stages. Understanding the available tests and when to use them can empower women to take a proactive approach to their health.

Both cervical and ovarian cancers can impact fertility, long-term wellness, and quality of life if left undiagnosed. Regular exams and appropriate testing are key to early identification and better treatment options.

Screening for cervical cancer

Cervical cancer screening is one of the most successful examples of preventive care in modern medicine. The cervix, located at the lower end of the uterus, can develop precancerous changes that are detectable through routine exams.

Two main tests are used:

Pap test (Pap smear): This test checks for abnormal cells on the cervix that may become cancerous over time.
HPV test: This looks for the presence of high-risk human papillomavirus strains, which are responsible for most cervical cancer cases.

For most women, screening begins at age 21 with Pap testing. Between ages 30 and 65, women may receive either a Pap test every three years, an HPV test every five years, or a combination of both every five years. After age 65, screening may stop if previous tests have been normal and there is no history of cervical disease.

Screening guidelines may be adjusted for individuals with weakened immune systems, a history of abnormal results, or those who have had a hysterectomy for cancer-related reasons.

What to expect during a Pap or HPV test

These tests are typically performed during a pelvic exam in a healthcare provider’s office. A speculum is used to gently open the vaginal walls so that cells can be collected from the cervix. The procedure takes just a few minutes and may cause mild discomfort, but it is not usually painful.

Results are usually returned within a week. If abnormalities are found, follow-up testing or a colposcopy (closer examination of the cervix) may be recommended to determine whether treatment or monitoring is needed.

Regular screening allows for early treatment of precancerous changes, often before they progress to cervical cancer.

Screening for ovarian cancer

Unlike cervical cancer, there is currently no standard or routine screening test for ovarian cancer in average-risk women. Ovarian cancer often develops without obvious symptoms, and by the time it is diagnosed, it may already be in an advanced stage.

Ovarian cancer begins in the ovaries or nearby fallopian tubes and can spread quickly within the abdominal cavity. Because of its subtle symptoms—such as bloating, pelvic pain, or changes in appetite—it is often mistaken for less serious conditions.

For women at higher risk, some screening tools may be considered:

Transvaginal ultrasound (TVUS): This imaging test can detect abnormalities in the ovaries, such as masses or cysts.
CA-125 blood test: This test measures a protein that is sometimes elevated in women with ovarian cancer.

However, these tests are not reliable enough to be used for routine screening in the general population. They may produce false positives, leading to unnecessary testing or procedures.

Who is at higher risk for ovarian cancer

Some individuals may benefit from closer monitoring based on personal or family history. Risk factors that may prompt discussion about ovarian cancer testing include:

A family history of ovarian, breast, or colorectal cancer
Known genetic mutations (such as BRCA1 or BRCA2)
A personal history of endometriosis or fertility treatment
Being over the age of 50 or having never given birth

In these cases, a healthcare provider may recommend genetic counseling, periodic imaging, or CA-125 testing. These tools are not definitive but can provide additional information when used as part of a broader risk management plan.

The importance of pelvic exams

Even though there is no formal screening test for ovarian cancer, routine pelvic exams remain important. During these exams, providers can detect abnormalities in size or shape of reproductive organs. While not diagnostic on their own, regular pelvic assessments help track changes and identify the need for further testing.

Pelvic exams also provide an opportunity to review symptoms, menstrual changes, or other signs that may signal a deeper concern. Any persistent discomfort, bloating, or irregular bleeding should be discussed with a provider.

Staying proactive with reproductive health

Early detection remains the best defense against reproductive cancers. For cervical cancer, adherence to regular screening schedules dramatically lowers the risk of invasive disease. For ovarian cancer, understanding personal risk factors and staying alert to persistent changes in health can lead to earlier diagnosis and improved outcomes.

Patients should communicate openly with their healthcare providers about any concerns, especially as they age or experience shifts in reproductive or hormonal health. Timely evaluation of symptoms and appropriate use of available tests support long-term well-being.